Su Cheng-Hao, Lin Yong, Cai Lin
Department of Emergency Countermeasure and Information Management, Xiamen Center for Disease Control and Prevention, Xiamen, China E-mail :
Asian Pac J Cancer Prev. 2013;14(9):4953-60. doi: 10.7314/apjcp.2013.14.9.4953.
Primary liver cancer is one of the most common cancers at the global level, accounting for half of all cancers in some undeveloped countries. This disease tends to occur in livers damaged through alcohol abuse, or chronic infection with hepatitis B and C, on a background of cirrhosis. Various cancer-causing substances are associated with primary liver cancer, including certain pesticides and such chemicals as vinyl chloride and arsenic. The strong association between HBV infection and liver cancer is well documented in epidemiological studies. It is generally acknowledged that the virus is involved through long term chronic infection, frequently associated with cirrhosis, suggesting a nonspecific mechanism triggered by the immune response. Chronic inflammation of liver, continuous cell death, abnormal cell growth, would increase the occurrence rate of genetic alterations and risk of disease. However, the statistics indicated that only about one fifth of HBV carries would develop HCC in lifetime, suggesting that individual variation in genome would also influence the susceptibility of HCC. The goal of this review is to highlight present level of knowledge on the role of viral infection and genetic variation in the development of liver cancer.
原发性肝癌是全球最常见的癌症之一,在一些不发达国家占所有癌症的一半。这种疾病往往发生在因酗酒或慢性感染乙型和丙型肝炎而受损的肝脏上,且伴有肝硬化背景。各种致癌物质与原发性肝癌有关,包括某些农药以及氯乙烯和砷等化学物质。乙型肝炎病毒感染与肝癌之间的紧密关联在流行病学研究中有充分记录。人们普遍认为,该病毒通过长期慢性感染发挥作用,这种感染常与肝硬化相关,提示免疫反应触发了一种非特异性机制。肝脏的慢性炎症、持续的细胞死亡、异常的细胞生长,会增加基因改变的发生率和患病风险。然而,统计数据表明,只有约五分之一的乙肝携带者会在一生中发展为肝癌,这表明基因组的个体差异也会影响肝癌的易感性。本综述的目的是强调目前关于病毒感染和基因变异在肝癌发生中作用的知识水平。